Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mRNA vaccines in the prevention and treatment of diseases. | MedComm (2020) | 2022 | 36033422 | PubTator, text mining | PubMed |
| Alternating exosomes and their mimetics as an emergent strategy for targeted cancer therapy. | Front Mol Biosci | 2022 | 36032679 | PubTator, text mining | PubMed |
| Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review. | Vaccines (Basel) | 2022 | 36016136 | PubTator, text mining | PubMed |
| Cancer Immunotherapy and Delivery System: An Update. | Pharmaceutics | 2022 | 36015256 | PubTator, text mining | PubMed |
| Genetic Variation in the MBL2 Gene Is Associated with Chlamydia trachomatis Infection and Host Humoral Response to Chlamydia trachomatis Infection. | Int J Mol Sci | 2022 | 36012556 | PubTator, text mining | PubMed |
| Application of lipid-based nanoparticles in cancer immunotherapy. | Front Immunol | 2022 | 36003395 | PubTator, text mining | PubMed |
| Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma. | Front Oncol | 2022 | 35992806 | PubTator, text mining | PubMed |
| Colorectal cancer vaccines: The current scenario and future prospects. | Front Immunol | 2022 | 35990683 | PubTator, text mining | PubMed |
| Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity. | Mol Immunol | 2022 | 35987136 | PubTator, text mining | PubMed |
| Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma. | Neurooncol Adv | 2022 | 35967100 | PubTator, text mining | PubMed |
| Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers. | Transl Oncol | 2022 | 35964339 | PubTator, text mining | PubMed |
| Implications of genetic heterogeneity in hepatocellular cancer. | Adv Cancer Res | 2022 | 35961697 | PubTator, text mining | PubMed |
| The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers-What Should a Urologist Really Know? | Int J Environ Res Public Health | 2022 | 35955004 | PubTator, text mining | PubMed |
| Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancer. | Comput Struct Biotechnol J | 2022 | 35950187 | PubTator, text mining | PubMed |
| Neoantigen-based cancer vaccination using chimeric RNA-loaded dendritic cell-derived extracellular vesicles. | J Extracell Vesicles | 2022 | 35927827 | PubTator, text mining | PubMed |
| Boosting Antitumor Immunity with an Expanded Neoepitope Landscape. | Cancer Res | 2022 | 35904353 | PubTator, text mining | PubMed |
| The Origin and Evolution of Bladder Cancer Stem Cells. | Front Cell Dev Biol | 2022 | 35903544 | PubTator, text mining | PubMed |
| The Contributions of Cancer-Testis and Developmental Genes to the Pathogenesis of Keratinocyte Carcinomas. | Cancers (Basel) | 2022 | 35892887 | PubTator, text mining | PubMed |
| Skin Cancer Research Goes Digital: Looking for Biomarkers within the Droplets. | J Pers Med | 2022 | 35887633 | PubTator, text mining | PubMed |
| Molecular and Circulating Biomarkers of Gastric Cancer. | Int J Mol Sci | 2022 | 35886934 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=24